You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 142 No. 2, February 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  The Cutting Edge: Challenges in Medical and Surgical Therapeutics
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (8)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Dermatologic Disorders, Other
 •Alert me on articles by topic

Treatment of Generalized Lichen Planus With Alefacept

David P. Fivenson, MD; Barbara Mathes, MD
Fivenson Dermatology, Ann Arbor, Mich (Dr Fivenson), and Biogen Idec, Inc, Cambridge, Mass (Dr Mathes)

Arch Dermatol. 2006;142:151-152.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

REPORT OF CASES

CASE 1

A 25-year-old white woman with a 2-year history of lichen planus (LP) presented with widespread violaceous, hyperpigmented, pruritic papules involving the upper part of the arms, forearms, abdomen, thighs, lower part of the legs, and lower back area (Figure, A). There were several lacy white patches without ulceration on the buccal mucosa of the mouth, but there was no vulvovaginal or scalp involvement. Previous treatments had included antihistamines, hydroxychloroquine sulfate, topical tacrolimus, systemic and topical corticosteroids, cyclosporine, griseofulvin, and narrow-band UV-B. Each systemic therapy was used for at least 3 months. The results of hepatitis screening were negative. The patient had no known medical allergies, and her medical history was unremarkable.


 
Figure appears in full text version.
Figure. Patient 1 before (A) and after (B) treatment with alefacept. A, Raised erythematous and violaceous papules on the posterior aspect of the calf. B, After 12 weeks of alefacept . . . [Full Text of this Article]


CASE 2

THERAPEUTIC CHALLENGE

SOLUTION

COMMENT

AUTHOR INFORMATION



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Combination Immunosuppressive Therapies: The Promise and the Peril
Robinson et al.
Arch Dermatol 2007;143:1053-1057.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.